Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species

ABSTRACT Fungal secondary metabolites are a rich source of valuable natural products, and genome sequencing has revealed a proliferation of predicted biosynthetic gene clusters in the genomes. However, it is currently an unfeasible task to characterize all biosynthetic gene clusters and to identify...

Full description

Bibliographic Details
Main Authors: Inge Kjærbølling, Tammi Vesth, Mikael R. Andersen
Format: Article
Language:English
Published: American Society for Microbiology 2019-08-01
Series:mSystems
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mSystems.00085-19
_version_ 1818742274835611648
author Inge Kjærbølling
Tammi Vesth
Mikael R. Andersen
author_facet Inge Kjærbølling
Tammi Vesth
Mikael R. Andersen
author_sort Inge Kjærbølling
collection DOAJ
description ABSTRACT Fungal secondary metabolites are a rich source of valuable natural products, and genome sequencing has revealed a proliferation of predicted biosynthetic gene clusters in the genomes. However, it is currently an unfeasible task to characterize all biosynthetic gene clusters and to identify possible uses of the compounds. Therefore, a rational approach is needed to identify a short list of gene clusters responsible for producing valuable compounds. To this end, several bioactive clusters include a resistance gene, which is a paralog of the target gene inhibited by the compound. This mechanism can be used to identify these clusters. We have developed the FRIGG (fungal resistance gene-directed genome mining) pipeline for identifying this type of biosynthetic gene cluster based on homology patterns of the cluster genes. In this work, the FRIGG pipeline was run using 51 Aspergillus and Penicillium genomes, identifying 72 unique families of putative resistance genes. The pipeline also identified the previously characterized resistance gene inpE from the fellutamide B cluster, thereby validating the approach. We have successfully developed an approach to identify putative valuable bioactive clusters based on a specific resistance mechanism. This approach will be highly useful as an ever-increasing amount of genomic data becomes available; the art of identifying and selecting the right clusters producing novel valuable compounds will only become more crucial. IMPORTANCE Species belonging to the Aspergillus genus are known to produce a large number of secondary metabolites; some of these compounds are used as pharmaceuticals, such as penicillin, cyclosporine, and statin. With whole-genome sequencing, it became apparent that the genetic potential for secondary metabolite production is much larger than expected. As an increasing number of species are whole-genome sequenced, thousands of secondary metabolite genes are predicted, and the question of how to selectively identify novel bioactive compounds from this information arises. To address this question, we have created a pipeline to predict genes involved in the production of bioactive compounds based on a resistance gene hypothesis approach.
first_indexed 2024-12-18T02:09:55Z
format Article
id doaj.art-f1d3beddecc046f2ab2eedfd768803fb
institution Directory Open Access Journal
issn 2379-5077
language English
last_indexed 2024-12-18T02:09:55Z
publishDate 2019-08-01
publisher American Society for Microbiology
record_format Article
series mSystems
spelling doaj.art-f1d3beddecc046f2ab2eedfd768803fb2022-12-21T21:24:31ZengAmerican Society for MicrobiologymSystems2379-50772019-08-014410.1128/mSystems.00085-19Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> SpeciesInge Kjærbølling0Tammi Vesth1Mikael R. Andersen2Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, DenmarkDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, DenmarkDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, DenmarkABSTRACT Fungal secondary metabolites are a rich source of valuable natural products, and genome sequencing has revealed a proliferation of predicted biosynthetic gene clusters in the genomes. However, it is currently an unfeasible task to characterize all biosynthetic gene clusters and to identify possible uses of the compounds. Therefore, a rational approach is needed to identify a short list of gene clusters responsible for producing valuable compounds. To this end, several bioactive clusters include a resistance gene, which is a paralog of the target gene inhibited by the compound. This mechanism can be used to identify these clusters. We have developed the FRIGG (fungal resistance gene-directed genome mining) pipeline for identifying this type of biosynthetic gene cluster based on homology patterns of the cluster genes. In this work, the FRIGG pipeline was run using 51 Aspergillus and Penicillium genomes, identifying 72 unique families of putative resistance genes. The pipeline also identified the previously characterized resistance gene inpE from the fellutamide B cluster, thereby validating the approach. We have successfully developed an approach to identify putative valuable bioactive clusters based on a specific resistance mechanism. This approach will be highly useful as an ever-increasing amount of genomic data becomes available; the art of identifying and selecting the right clusters producing novel valuable compounds will only become more crucial. IMPORTANCE Species belonging to the Aspergillus genus are known to produce a large number of secondary metabolites; some of these compounds are used as pharmaceuticals, such as penicillin, cyclosporine, and statin. With whole-genome sequencing, it became apparent that the genetic potential for secondary metabolite production is much larger than expected. As an increasing number of species are whole-genome sequenced, thousands of secondary metabolite genes are predicted, and the question of how to selectively identify novel bioactive compounds from this information arises. To address this question, we have created a pipeline to predict genes involved in the production of bioactive compounds based on a resistance gene hypothesis approach.https://journals.asm.org/doi/10.1128/mSystems.00085-19Aspergilluscomparative genomicsgenome miningbioactive compoundsfungalgenomes
spellingShingle Inge Kjærbølling
Tammi Vesth
Mikael R. Andersen
Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
mSystems
Aspergillus
comparative genomics
genome mining
bioactive compounds
fungal
genomes
title Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
title_full Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
title_fullStr Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
title_full_unstemmed Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
title_short Resistance Gene-Directed Genome Mining of 50 <italic toggle="yes">Aspergillus</italic> Species
title_sort resistance gene directed genome mining of 50 italic toggle yes aspergillus italic species
topic Aspergillus
comparative genomics
genome mining
bioactive compounds
fungal
genomes
url https://journals.asm.org/doi/10.1128/mSystems.00085-19
work_keys_str_mv AT ingekjærbølling resistancegenedirectedgenomeminingof50italictoggleyesaspergillusitalicspecies
AT tammivesth resistancegenedirectedgenomeminingof50italictoggleyesaspergillusitalicspecies
AT mikaelrandersen resistancegenedirectedgenomeminingof50italictoggleyesaspergillusitalicspecies